These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22100691)

  • 1. Oppositional defiant disorder in adults with ADHD.
    Reimherr FW; Marchant BK; Olsen JL; Wender PH; Robison RJ
    J Atten Disord; 2013 Feb; 17(2):102-13. PubMed ID: 22100691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD.
    Harpold T; Biederman J; Gignac M; Hammerness P; Surman C; Potter A; Mick E
    J Nerv Ment Dis; 2007 Jul; 195(7):601-5. PubMed ID: 17632251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.
    Reimherr FW; Marchant BK; Williams ED; Strong RE; Halls C; Soni P
    Ann Clin Psychiatry; 2010 May; 22(2):103-12. PubMed ID: 20445837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.
    Marchant BK; Reimherr FW; Robison RJ; Olsen JL; Kondo DG
    J Atten Disord; 2011 May; 15(4):295-304. PubMed ID: 20410322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates of oppositional defiant disorder and attention-deficit/hyperactivity disorder in adults.
    Weiss MD; Wasdell M; Gadow KD; Greenfield B; Hechtman L; Gibbins C
    Postgrad Med; 2011 Mar; 123(2):177-84. PubMed ID: 21474906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysthymic disorder contributes to oppositional defiant behaviour in children with Attention Deficit Hyperactivity Disorder, combined type (ADHD-CT).
    Vance A; Sanders M; Arduca Y
    J Affect Disord; 2005 Jun; 86(2-3):329-33. PubMed ID: 15935256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?
    Connor DF; Doerfler LA
    J Atten Disord; 2008 Sep; 12(2):126-34. PubMed ID: 17934178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.